Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
OBJECTIVE
This is part 2 of a 2-part review. Research into the molecular mechanisms underlying the various aspects of prostate cancer (PCa) requires the use of in vivo and in vitro model systems. In the last few years many new cell lines have been established by investigators from primary tissue sources and clonal derivatives of previously established lines. Therefore, the purpose of this 2-part review is to catalogue the current human cell lines developed for PCa research, as reported in the literature. Part 2 describes tissue culture cell lines derived by the insertion of transgenes, including human telomerase reverse transcriptase, SV40 T antigen and human papillomavirus genes. Part 2 also includes xenograft lines that require propagation and passage in vivo in mice.


METHODS
Prostate cell lines included in this review were identified by extensive searching of the literature using several strategies, including PubMed searches and book chapter reviews.


RESULTS
In total we describe the derivation, phenotype, genotype and characterization of molecular markers expressed by approximately 200 lines and sublines used in PCa research, including ones derived from primary tumors, metastases and normal prostate tissue. We paid particular attention to the expression of prostate specific antigen, androgen receptor, cytokeratins and other molecular markers used to indicate the status of PCa and the prostatic lineage of a given line. In an attempt to provide PCa researchers with a resource of information regarding new and established cell lines we have also created an online database of these PCa cell lines freely accessible via the World Wide Web at http://www.CaPCellLines.com. The web based interface allows researchers to peruse and print information regarding cell lines, add new cell lines and update or add new information regarding established cell lines.


CONCLUSIONS
This compendium of cell lines currently used in PCa research combined with access to our on-line database provides researchers with a continually updated and valuable resource for investigating the molecular mechanisms of PCa.
Sobel
R E
RE
Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. rsobel@bccrc.ca
Sadar
M D
MD
D000952:Antigens, Polyomavirus Transforming; D035843:Biomedical Research; D045744:Cell Line, Tumor / Q000637:transplantation; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental; D011471:Prostatic Neoplasms / Q000473:pathology*
D000952:Antigens, Polyomavirus Transforming